Preoperative Serum Raman Spectroscopy: A Rapid, Label-Free Predictor of Postoperative Pulmonary Infection After Off-Pump Coronary Artery Bypass Grafting

Scritto il 01/05/2026
da Yuan Hui

J Cardiothorac Vasc Anesth. 2026 Apr 1:S1053-0770(26)00272-7. doi: 10.1053/j.jvca.2026.03.040. Online ahead of print.

ABSTRACT

OBJECTIVE: This study aimed to develop and validate a preoperative risk-stratification tool based on serum Raman spectroscopy to identify patients at high risk for postoperative pulmonary infection (PPI) following off-pump coronary artery bypass grafting (OPCABG).

DESIGN: A prospective diagnostic cohort study.

SETTING: The study was conducted at a single academic medical center.

PARTICIPANTS: A total of 276 adult patients undergoing OPCABG were enrolled. Preoperative serum samples were collected from all participants.

INTERVENTIONS: Preoperative serum was analyzed using 532 nm confocal Raman spectroscopy (400-1,800 cm-1). Participants were randomly split 7:3 into training and test sets for model development and validation.

MEASUREMENTS AND MAIN RESULTS: PPI within 72 hours was adjudicated by Centers for Disease Control and Prevention/National Healthcare Safety Network criteria. Fifty-seven patients (20.7%) developed early PPI. After feature selection via 2-sample t-test, LASSO regularization, and multivariable logistic regression, a 2-peak Raman signature (664 cm-1 and 842 cm-1) was identified. The final logistic model demonstrated strong performance on the test set, with an area under the receiver operating characteristic curve of 0.794 (95% confidence interval: 0.676-0.912), sensitivity of 70.6%, specificity of 72.7%, and a Brier score of 0.133. SHapley Additive exPlanations analysis confirmed that elevated intensities at these peaks were associated with increased early PPI risk. Decision-curve analysis indicated net clinical benefit across threshold probabilities of 15% to 35%.

CONCLUSIONS: A rapid reagent-free serum Raman signature comprising 2 peaks (664 cm-1 and 842 cm-1) provides an interpretable and effective preoperative prediction of early PPI risk in OPCABG patients, as demonstrated by internal validation.

PMID:42067408 | DOI:10.1053/j.jvca.2026.03.040